Email
Print-Friendly
SubscribeHIV Care Today
By Paul E. Sax, M.D.
July 28, 2011
Just back from IAS 2011 (which was followed, I'm thrilled to say, with a visit to perhaps the most beautiful region in the world). Here is a Really Rapid ReviewTM of the meeting, with apologies ahead of time for lack of organization and (even more likely) leaving out something important. FYI, the abstracts are online here; I'm sure there's a place on the meeting homepage that has the same link, but I can't seem to find it.
By Jeannie Wraight
July 21, 2011
Groundbreaking results of two large pre-exposure prophylaxis (PrEP) studies may lead to a new prevention option to reduce HIV transmission. Data released on two PrEP studies showed high levels of protection against HIV infection when tenofovir (Viread) or Truvada (tenofovir and emtricitabine) were taken daily by HIV-uninfected individuals at high risk for infection.
By Bethsheba Johnson, G.N.P.-B.C., A.A.H.I.V.S.
July 18, 2011
In my current practice, every day there is at least one man over the age of 50 asking for an erectile dysfunction (ED) medication. It seems to have become an epidemic. Or it is just more openly discussed. Or both.
By Paul E. Sax, M.D.
July 14, 2011
As part of the usual flurry of studies released just before major scientific meetings, results of two pre-exposure prophylaxis (PrEP) trials in heterosexual men and women have just been made public:
By Paul E. Sax, M.D.
July 12, 2011
The result of the above stellar behavior? I would do virtually anything to try and help her. Back in the late 1990s, when she was very sick with AIDS, one of my fellows said it best: "There's just something about her that makes you want to take care of her." Exactly.
By David Fawcett, Ph.D., L.C.S.W.
July 12, 2011
It was the peak time for the cherry blossoms in Washington, D.C. -- or so I was told. I only caught a glimpse of them from the Metro as I was riding in from Reagan National, and a few times out the window of the hotel conference room (along with rain and even a brief burst of hail during that tempestuous spring weekend). But I wasn't in town for sightseeing: I was one of about 15 individuals from around the country selected to participate in the Training of Trainers program, a component of the National Association of Social Workers' HIV/AIDS Spectrum: Mental Health Training and Education of Social Workers Project.
By Bethsheba Johnson, G.N.P.-B.C., A.A.H.I.V.S.
July 7, 2011
A while back, after a challenging day in the office, I came home to the pleasure of reading the Winter 2011 edition of HIV Specialist, the magazine of the American Academy of HIV Medicine (AAHIVM). Of particular interest to my weary brain was an article by Bruce J. Packett II entitled "The Evolution of Viral Load Technologies."
By Nelson Vergel, B.S.Ch.E., M.B.A.
July 6, 2011
Of the HIV medications in development with potential activity against highly resistant HIV (i.e., patients with GSS=0), two may become available within the next year: ibalizumab (formerly TNX-355), a monoclonal antibody currently under development by TaiMed Biologics, and dolutegravir (formerly GSK1349572), a second-generation integrase inhibitor made by ViiV Healthcare).
By Paul E. Sax, M.D.
June 24, 2011
The studies on abacavir and its potential association with increased cardiovascular risk have been inconsistent ever since the news first broke at CROI 2008. But recently the data have been swirling around so fast and furious that it seems appropriate to take out this famous Greek epithet.
By David Fawcett, Ph.D., L.C.S.W.
June 21, 2011
Every spring, on the white, sandy beaches of the Florida Panhandle, an unlikely gathering takes place. On that narrow strip of land, between the Gulf of Mexico and Choctawhatchee Bay, 450 HIV-positive men and women from around the country, but mostly from the Southeast, come together amidst occasional spring breakers for a weekend of socializing, education, some silliness, a few tears, and just plain fun.
Get email notifications every time HIV Care Today is updated.
This article was provided by TheBodyPRO.com. HIV Care Today is a multi-author blog featuring people on the frontlines of HIV treatment, prevention and patient/client care. This blog serves as a platform for these health care professionals to discuss the everyday challenges of their jobs, recent developments in their fields and issues relevant to the evolution of HIV/AIDS care.
Subscribe to This Blog:
 | By RSS  |
 | |
Bloggers and Contributors:
- David Fawcett, Ph.D., L.C.S.W.
- Lisa Fitzpatrick, M.D., M.P.H.
- Bethsheba Johnson, G.N.P.-B.C., A.A.H.I.V.S.
- Paul E. Sax, M.D.
- Nelson Vergel, B.S.Ch.E., M.B.A.
Recent Posts:
May 6, 2013 - MyHIVclinic.org: Rethinking How We Learn to Practice HIV Medicine
May 2, 2013 - How to Interpret Medical Breakthroughs in the Mainstream Media
April 30, 2013 - Lost and Found: Helping Patients Develop Emotional Resilience: A Blog Entry by David Fawcett, Ph.D., L.C.S.W.
April 29, 2013 - Data Safety Monitoring Board Closes HIV Vaccine Study -- the End of Adenovirus as a Vaccine Vector?
A Brief Disclaimer:
The opinions expressed by TheBodyPRO.com's bloggers are entirely their own, and do not necessarily reflect the views of TheBodyPRO.com itself.
TheBodyPRO.com: About TheBodyPRO.com | Contact TheBodyPRO.com | Content Policy | Advertise With Us
Remedy Health Media: About Remedy Health Media | Contact Remedy Health Media | Terms of Use | Privacy Policy
TheBodyPRO.com is a service of Remedy Health Media, LLC, 500 5th Avenue, 19th Floor, New York, NY 10110. TheBodyPRO.com and its logos are trademarks of Remedy Health Media, LLC, and its subsidiaries, which owns the copyright of TheBodyPRO.com's homepage, topic pages, page designs and HTML code. General Disclaimer: TheBodyPRO.com is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through TheBodyPRO.com should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.
